相关实验视频
Updated: Jul 6, 2025

08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
7.6K
在默克尔细胞癌中与瘤相关的巨细胞:旧的平衡,新的检查
1Dana-Farber Cancer Institute, Boston, MA, United States.
概括
表达S100A8的瘤相关巨细胞 (TAMs) 与默克尔细胞癌 (MCC) 中抗PD-(L) 1免疫疗法的耐药性有关. 准髓质检查点可以在没有反应瘤的患者中克服这种抵抗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 默克尔细胞癌 (MCC) 是一种侵袭性皮肤癌.
- 免疫疗法,特别是抗PD-(L) 1抑制剂,在治疗MCC时表现有前途.
- 然而,尽管存在瘤透淋巴细胞 (TILs),但一些患者对这些疗法没有反应.
研究的目的:
- 研究瘤相关巨细胞 (TAMs) 在MCC中的作用.
- 探索特定的TAM子集与抗PD-L) 1抑制剂的耐药性之间的关联.
- 确定潜在的治疗点,以改善MCC的免疫疗法反应.
主要方法:
- 在MCC瘤中分析TAMs.
- 在TAM中S100A8表达与对抗PD-(L) 1治疗的临床反应的相关性.
- 评估TIL在免疫疗法耐药病例中的影响.
主要成果:
- 在MCC中确定了一组表达S100A8的TAMs子集.
- 表达S100A8的TAMs的存在与抗PD-(L) 1抑制剂的耐药性有关.
- 这些发现有助于解释一些具有高TILs的MCC瘤对免疫疗法的不响应.
结论:
- 表达S100A8的TAMs在MCC中代表了抗PD-(L) 1治疗的耐药性机制.
- 准髓质检查点是克服免疫疗法耐药性的可行策略.
- 进一步研究髓质检查点抑制剂对于MCC治疗是有必要的.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

